The participants were 197 men and 196 women with a reported mean age of 21.6 years and a standard deviation of 1.5 years. Fourth-year students formed the largest group, numbering 229, or 58.3%, while 164 students were in their third year. Most respondents, 358 or 91.1%, were enrolled in a regular bachelor of nursing program, and 35 were in a bridging program for people who already held nursing diplomas.

Only 35 respondents, or 8.9%, had worked in a healthcare setting before entering the bachelor’s program, while 15, or 3.8%, reported attending an extracurricular pain-management course. Prior use of a pain scale was much more common: 329 students, or 83.7%, said they had used one. Learning about pain across laboratories, simulation and clinical placements was reported by 260 students, or 66.2%.

< Researchers used the Knowledge and Attitudes Survey Regarding Pain, a tool developed in 1987 and updated in 2014, with the original authors approving an Arabic translation for the study. The translation process included recruitment of translators, forward translation, backward translation, consolidation by a committee and pilot testing.

Minor contextual changes included replacing acetaminophen with paracetamol and replacing a reference to the United States with Saudi Arabia. Ten nursing experts with pain-management expertise evaluated the content validity of the translated survey. The scale-level content validity index was 0.98, the universal-agreement scale-level index was 0.85, and the Arabic instrument’s Cronbach’s alpha was 0.70.

Scores below 50% were classified as poor, scores from 50% to 75% as fair, and scores above 75% as good. < Students performed relatively well on selected statements about opioids.

A total of 92.4% correctly identified the definition of drug or opioid analgesic addiction, 89.8% said subsequent opioid doses should be adjusted according to the patient’s response, and 88.8% recognized the need to assess analgesic effects to avoid over-analgesia and respiratory difficulty. Yet these strengths were not consistent across the survey: only 16 of its 41 questions were answered correctly by more than half of the participants. The lowest results involved routes and doses of opioid administration, expected respiratory effects, tolerance and dependence, and two clinical case scenarios.

The survey therefore captured a mixture of correct factual knowledge and substantial gaps in applying that knowledge. < Several responses differed from the correct answers recorded by the survey.

Three-quarters of students incorrectly believed that patients should be encouraged to endure pain as much as possible before receiving opioids. Ninety percent did not identify oral administration as the recommended method for morphine in persistent cancer pain, and 86% believed that clinically evident respiratory distress was likely when an intravenous morphine dose was increased. Only 44.3% chose the patient as the person most capable of assessing pain severity; 26% selected the nurse, 19% the physician and 5% the patient’s spouse or family member.

More than 80% regarded administration of sterile water as an effective test for determining whether pain was real. These findings describe students’ survey responses rather than their behavior in clinical care. <

The two case studies tested assessment and intervention decisions in patients of the same age who had undergone the same surgical procedure and reported the same pain score, but who displayed different outward behavior. In case study A, the patient was smiling and relaxed; in case study B, the patient was grimacing and uncomfortable. About 30% of participants correctly scored pain in each scenario.

Only 5% selected the appropriate intervention involving 3 mg of intravenous morphine for the relaxed patient, and 8% selected it for the grimacing patient. The corresponding case-study responses produced some of the lowest correct-answer rates in the survey, indicating difficulty applying pain assessment and analgesic decisions even when the scenarios shared basic information. <

Survey performance was not significantly associated with gender, year of enrollment, type of nursing program, previous healthcare work, attendance at an extracurricular pain-management course, prior pain-scale use, learning context, or frequency of pain-scale use. Educational institution was the only demographic characteristic associated with performance in at least one analysis. A Kruskal–Wallis test found differences among the four universities when scores were treated as continuous.

Post hoc testing with Bonferroni correction showed that University A had significantly lower performance than Universities B and C. In robust linear regression, Universities B and C had higher continuous scores than the reference institution, while University D did not reach the conventional significance threshold. In the categorical logistic model, University C was associated with higher odds of a fair or good score than University A, but the corresponding categorical test across institutions had a p-value of 0.09.

< The findings extend earlier Saudi surveys that also reported low mean scores. The current study’s mean of 44% was similar to the approximately 42% reported in one earlier English-language survey and the 43% reported in another.

Those earlier investigations also identified language as a possible limitation for students whose first language was not English. By using an Arabic translation and recruiting senior male and female students from several institutions, the present survey addressed part of that concern and expanded the sample beyond the 150 participants in one earlier study. It did not test whether translation or any other methodological change improved learning, however, and the absence of a longitudinal or interventional design means that the causes of the low scores remain undetermined.

< The results provide a baseline for examining how pain management is incorporated into Saudi nursing programs. In the universities studied, pain management was addressed within selected subjects rather than as a discrete subject, using lectures, tutorials, simulation and clinical-placement experience.

The researchers recommended that educators and policymakers review curricula, resources and teaching methods, while suggesting particular attention to simulation, analgesic pharmacology, opioid administration and safety, patient-centered pain assessment, and communication with people experiencing pain. They also recommended broader studies involving additional institutions, practicing nurses and qualitative methods to investigate the factors associated with students’ low performance. These recommendations follow from the measured survey gaps, but the study did not implement or evaluate an educational intervention.

Several limitations constrain the interpretation of the findings. Because the study was cross-sectional, it can identify associations but cannot demonstrate causation. The sample came from only four purposively selected universities in one geographic region, so the results cannot be generalized to all Saudi nursing students.

Online self-reporting through the Knowledge and Attitudes Survey Regarding Pain may also introduce social-desirability bias, while the study’s recruitment and university selection were not described as nationally representative. The survey’s scoring system combines knowledge and attitudes, limiting the extent to which either can be isolated. Within those boundaries, the clearest reported findings are the low average score, the concentration of incorrect answers in pain assessment and opioid-related cases, and the absence of statistically significant relationships with most measured demographic and educational variables.

Subject of Research: Pain-management knowledge and attitudes among senior nursing students in northern Saudi Arabia

Article Title: Nursing Student's Knowledge of and Attitudes Towards Pain Management: A Cross‐Sectional Study

Article References: Alshehri, F. A., Levett‐Jones, T., Pich, J., & Alamri, A. S. (2026). Nursing Student's Knowledge of and Attitudes Towards Pain Management: A Cross‐Sectional Study. Nursing Open, 13(10), Article e70880. https://doi.org/10.1002/nop2.70880

Image Credits: AI Generated

DOI: 10.1002/nop2.70880

Keywords: pain management, nursing education, Saudi Arabia, nursing students, opioid safety, pain assessment, clinical decision-making, survey research, medical simulation, Nursing, Student's, Knowledge

The study’s methodological choices deserve closer attention because they shape what the findings can and cannot tell us. Descriptive phenomenology, as adapted from Colaizzi’s framework, is designed to capture lived experience as participants themselves describe it, rather than to impose pre-existing categories or measure pain intensity on a numerical scale. In this case, the researchers worked with fifteen Tibetan children recruited from a single pediatric hematology-oncology ward in Sichuan between February and March 2026. Purposive sampling of this kind is standard for phenomenological work, since the goal is depth of understanding rather than statistical generalizability. What makes this study distinctive, however, is not the sample size but the deliberate adaptation of interview technique: rather than relying on conventional verbal questioning alone, the team used play-based, semi-structured face-to-face interviews. This matters enormously when working with children, whose capacity to articulate internal states is constrained by developmental stage, and doubly so when the children are navigating interviews in a language and clinical environment shaped by a culture different from their own.

The first theme, cultural and spiritual interpretations of pain, points to something that pediatric pain research has increasingly recognized but that clinical practice has been slow to absorb: pain is not merely a sensory signal to be rated on a scale. For many Tibetan children in the study, pain was understood through frames of silent endurance and religious or traditional coping. Silent endurance is particularly consequential in oncology settings. Modern pain management depends heavily on patients and families reporting pain so that analgesia can be titrated appropriately. A child who believes that enduring pain quietly is virtuous, or who interprets suffering through a spiritual lens that discourages complaint, may systematically under-report pain. This creates a real risk of undertreatment, which in pediatric hematology-oncology is not a trivial matter. Poorly controlled pain in children has been associated in the broader literature with short-term distress and with longer-term consequences, including heightened pain sensitivity and fear of medical procedures later in life. The study’s finding suggests that nurses and physicians working with Tibetan children should not assume that the absence of complaint equals the absence of pain.

The second theme, linguistic and communicative constraints, adds a practical layer to this problem. The children in the study faced limited Mandarin vocabulary for describing pain and tended to express discomfort indirectly. China’s clinical environment, particularly in major referral hospitals, operates predominantly in Mandarin, while many Tibetan children grow up speaking Tibetan at home. Pain vocabulary is notoriously difficult even within a shared language; children typically acquire pain descriptors gradually, and abstract terms like aching, throbbing, or stabbing may not map cleanly onto words in another language. When a child must translate bodily sensation from Tibetan into Mandarin, and then compress that translation into vocabulary appropriate for a young age, the resulting report may be vague, delayed, or conveyed through behavior rather than words. Indirect expression, such as describing a symptom through its effect on play or appetite rather than naming the pain itself, requires clinicians to listen for meaning rather than waiting for a direct statement. The study’s authors suggest that pain assessment in this population may benefit from child-centered communication and attention to nonverbal cues, which aligns with established best practice in pediatric pain measurement, where observational and behavioral tools supplement self-report for younger children.

The third theme, the family-centered dimension of pain, resonates with a well-documented feature of pediatric care but takes on particular cultural texture here. The children described emotional security through family presence, relational continuity through family accompaniment, and comfort drawn from familiar family-based practices. In pediatric oncology across many settings, family presence at the bedside is associated with reduced distress, better coping with procedures, and improved communication of symptoms. But the study suggests something more specific: for these Tibetan children, family members were not merely comforting presences but active participants in the pain experience itself, serving as interpreters, advocates, and providers of culturally familiar comfort practices. This has operational implications. Hospital policies that restrict visitation, or assessment protocols that interview children in isolation from family members, may inadvertently strip away a key layer of the child’s coping resources. At the same time, clinicians must balance the value of family accompaniment against the need to hear the child’s own account, since family members may filter or reframe a child’s pain reports in ways that reflect their own cultural interpretations.

The fourth theme extends the picture beyond the hospital ward. The children described disrupted schooling and loss of peer contact, along with worries about illness disclosure and social isolation. This dimension of the pain experience is sometimes labeled psychosocial, but the study’s framing treats it as integral to how pain is lived rather than as a separate category. For a child with a hematologic malignancy, hospitalization interrupts the developmental work of school attendance, friendship, and identity formation. Concerns about who will learn about the illness, and how classmates will respond, add a social dimension to suffering that can amplify the experience of physical pain or make children reluctant to report symptoms that might extend their hospital stay. Research on childhood cancer more broadly has consistently identified peer disconnection and school disruption as major sources of distress, and the present study suggests these concerns are intertwined with how pain itself is communicated and endured.

Taken together, the four themes sketch a model in which pain for these children is simultaneously a bodily sensation, a moral and spiritual matter, a linguistic challenge, a family event, and a social disruption. No single assessment tool captures all of these dimensions. Standard pediatric pain scales, whether self-report faces scales or observational measures, are designed to quantify intensity, not to surface the interpretive frameworks through which a child understands suffering. The study’s conclusion that culturally responsive assessment should attend to indirect and nonverbal expression, and to the supportive role of family, is therefore not simply a call for politeness or cultural sensitivity as an add-on. It is a claim that the standard instruments and routines of pain assessment may systematically misread children whose cultural and linguistic backgrounds differ from the assumptions embedded in those tools.

It is worth noting what a descriptive phenomenological study of fifteen children in one ward can and cannot establish. The findings are not prevalence estimates; they do not tell us how common silent endurance or indirect expression is among Tibetan children with cancer in general, nor can they be generalized to other ethnic minority populations in China or elsewhere. What they offer is a carefully documented account of lived experience that can generate hypotheses for quantitative testing and, more immediately, inform the design of assessment practices, interpreter involvement, family accommodation policies, and nursing education in pediatric hematology-oncology settings that serve Tibetan and other minority-language children. The study also joins a small but growing body of literature on culturally responsive pediatric pain care, a field in which most published instruments and protocols have been developed in Western, English-speaking contexts and validated elsewhere only unevenly.

For clinicians, the practical takeaways are concrete. Ask children about pain in ways that allow indirect answers; watch behavior rather than relying solely on verbal report; involve family members as partners while still seeking the child’s own voice; and recognize that a quiet, stoic child may be enduring significant pain rather than experiencing none. For researchers, the study opens questions about whether similar patterns of silent endurance and indirect expression appear in other cultural groups, how play-based interview methods can be standardized and scaled, and whether culturally adapted pain assessment tools improve outcomes such as analgesic adequacy and child-reported distress. For the children themselves, whose voices the study deliberately centers, the message is that pain is not only what a scale says it is, and that being understood requires those around them to attend to language, faith, family, and friendship as much as to the pain itself.

Subject of Research: Pain experiences of Tibetan children with hematologic malignancies in China

Article Title: Pain experiences of Tibetan children with hematologic malignancies in China: A descriptive phenomenological study

Article References: Chen, Y., Liu, Y., Zhou, J., Pu, H., & Zhang, J. (2026). Pain experiences of Tibetan children with hematologic malignancies in China: A descriptive phenomenological study. PLOS One, 21(10), e0360911. https://doi.org/10.1371/journal.pone.0360911

Image Credits: AI Generated

DOI: 10.1371/journal.pone.0360911

Keywords: pain, Tibetan children, hematologic malignancies, pediatric oncology, phenomenology, cultural competence, pain assessment, nursing care, China, qualitative research, experiences, Tibetan

Cancer pain is extraordinarily common. According to a 2023 systematic review and meta-analysis cited in the report, the overall prevalence of pain among cancer patients is 44.5 percent, with roughly 30.6 percent experiencing moderate to severe pain. Among patients with advanced, metastatic, or end-stage disease, the prevalence climbs to 54.6 percent. Most of these patients achieve reasonable relief through oral or topical medications organized along the World Health Organization analgesic ladder. But an estimated 10 to 20 percent of those with moderate-to-severe cancer pain never obtain effective relief, or they abandon treatment because of intolerable side effects. These cases are defined as refractory cancer pain, and they represent a vicious physiological cycle in which persistent severe pain triggers central sensitization, placing the nervous system in a state of abnormally heightened and sustained sensitivity. Pain not only causes direct suffering but also amplifies its own signals through emotional and physiological mechanisms, elevating stress hormones, increasing cardiovascular demand, and impairing immune function, which may in turn accelerate disease progression.

The central technical argument of the new report is that traditional assessment tools are simply too narrow to capture this complexity. Clinicians have long relied on unidimensional instruments such as the numeric rating scale and the visual analogue scale, which reduce the entire pain experience to a single number, as well as on multidimensional questionnaires like the Brief Pain Inventory and neuropathic pain screening scales. All of these depend on patient subjectivity, which inherently biases the scores and can push treatment regimens away from optimal protocols. Neurophysiological testing offers objective data, but high equipment costs and technical complexity have limited its widespread clinical utility. The 6D BTS system was designed to fill this gap by combining multidimensional depth with objectivity and ease of use through a digital interface.

The Botong score comprises six dimensions. The first is the numeric rating scale itself, ranging from 0 for no pain to 10 for the worst pain imaginable, with scores of 1 to 3 reflecting mild pain, 4 to 6 moderate pain, and 7 to 10 severe pain. The second dimension assesses the impact of pain on physical function, with separate regional queries covering cervical spine, upper limb, lower back, and lower limb function, each scored from 0 for no impact to 10 for the most serious impact. The third and fourth dimensions measure the impact of pain on emotions and on sleep, using the same 0 to 10 range. The fifth dimension screens for neuropathic pain using the LANSS scale, in which affirmative responses to questions about needling stabbing pain, burning pain, tingling sensations, electric-shock-like pain, and pain exacerbated by touching clothes or sheets each add one point, while an affirmative response to a sixth question subtracts one point; scores of 2 to 3 suggest neuropathic pain and scores of 4 to 5 strongly suggest it. The sixth dimension assesses breakthrough pain, asking whether sudden, brief, unbearable severe pain occurs even when analgesics are otherwise controlling the baseline pain, including when body position changes.

Psychometric testing supports the instrument. Reliability analysis yielded a Cronbach’s alpha coefficient of 0.78 for the BTS, and validity analysis produced a KMO value of 0.80, indicating good reliability and construct validity. A randomized crossover trial published in Pain Therapeutics in 2023 compared the digital multidimensional Botong score with the Brief Pain Inventory for evaluating cancer-related pain and found the BTS could compensate for some of the BPI’s deficiencies. Notably, the BPI requires complex color-coding on body maps, a task frequently too difficult for elderly patients, whereas the BTS system employs voice-activated control and simplified queries to ensure accessibility. In the new case report, a robot equipped with the BTS 6D system visited the patient’s bedside, administered the questionnaire, and organized the results, remaining unaffected by healthcare staff and delivering standardized, objective scoring with a high detection rate.

The patient’s history illustrates why such comprehensive assessment matters. He had undergone laparoscopic cholecystectomy with extended radical resection and partial hepatectomy for gallbladder carcinoma in February 2022 at another hospital, where histopathology revealed moderately to well-differentiated adenocarcinoma invading the serosal layer with perineural invasion and metastases in both lymph nodes at the porta hepatis, staged T3N1Mx. Four cycles of oral capecitabine followed. In October 2022, clavicular metastasis was detected and treated with 25 sessions of localized radiotherapy. In May 2023, chest pain prompted imaging that suggested sternal metastasis, leading to another 25 radiotherapy sessions targeting the sternum plus two cycles of a GP chemotherapy regimen. Severe myelosuppression after each cycle forced discontinuation of further chemotherapy. Over the preceding year, his intermittent stabbing chest pain had escalated from self-managed codeine and ibuprofen to oxycodone extended-release tablets at 50 mg every 12 hours combined with pregabalin and celecoxib, with morphine suppositories for breakthrough episodes. In the five days before presentation, pain intensity surged, destroying his sleep and appetite.

On admission, the patient was cachectic with a Karnofsky Performance Status score of 60, confined to a forced supine position, with post-radiation hyperpigmentation across his chest, two firm palpable subcutaneous nodules roughly 2 cm in diameter, an enlarged tender lymph node in the right supraclavicular fossa, fine crackles in the right lung fields, and pitting edema in the lower extremities. His diagnoses included gallbladder carcinoma at stage IVB with multiple secondary bone, hepatic, pulmonary, and left adrenal malignancies, plus chronic refractory chest and back pain. The robot-assisted BTS evaluation localized his primary pain to the chest and back, characterized by stabbing and burning sensations, and quantified regional impact scores of 4 for the cervical spine, 3 for the upper limbs, 6 for the lumbar and dorsal regions, and 7 for the lower limbs. Sleep impact registered 9 and emotional impact 10. Screening identified a neuropathic pain component with a score of 3, and he reported six daily breakthrough episodes, significantly exacerbated by postural changes. In accordance with the 2017 Expert Consensus on Refractory Cancer Pain, the team designed a tailored multimodal analgesic regimen addressing this complex profile.

On January 3, 2024, the team initiated intravenous hydromorphone patient-controlled analgesia at a concentration of 0.6 mg/mL, with a basal rate of 1.3 mL/h, a 3.2 mL bolus, a 15-minute lockout interval, and an hourly limit of 10.9 mL. Baseline control was initially adequate, but three breakthrough episodes occurred within the first 12 hours. Titration on January 5 to a 1.5 mL/h basal rate and 3.6 mL bolus brought the NRS to 3 with three daily breakthrough episodes. By January 7, pain had rebounded to NRS 6 with six daily episodes occurring predominantly at night. The team added pregabalin and olanzapine and adjusted the PCA to a 2.5 mL/h basal rate and 4.5 mL bolus, achieving stable control at NRS 3 with only one daily episode. Critically, the BTS data identified the pain as classic incident pain triggered by movement or postural changes, so the patient was instructed to self-administer pre-emptive PCA boluses before physical activity. Laxatives and dietary modifications prevented opioid-induced constipation. By January 13, when he transferred to a local hospital continuing intravenous PCA, his NRS was 1 with no breakthrough episodes, and remote monitoring through the BTS digital health system confirmed stable analgesia at NRS 2 by January 20, with regional impact scores collapsing toward zero and the neuropathic component down to 1.

The patient’s own words capture what the numbers mean. Before treatment, he reported that his pain destroyed his will to live, and stated that his greatest fear was not death but dying in agony. After achieving adequate analgesia, he told the nursing staff that he could now say goodbye to his children without screaming in pain. The authors emphasize that the real harm of cancer pain lies not only in physical suffering but in the erosion of dignity and meaningful connection at the end of life. They also acknowledge important limitations: as the BTS is an assessment instrument, the observed analgesic benefit is attributable to the therapeutic regimen it informed rather than to the tool itself, and this single case cannot isolate the incremental contribution of multidimensional assessment over standard titration. The patient succumbed to disease progression one month after discharge, precluding long-term follow-up data.

Even so, the case demonstrates that multidimensional digital assessment proved feasible and provided clinically relevant information that may offer a foundation for hypothesis testing in subsequent controlled trials. The authors argue that investigations should now focus on full-cycle management and real-time surveillance of refractory pain, maximizing quality of life for cancer patients. If the 6D BTS system and its robotic interface can be validated at scale, the integration of artificial intelligence, standardized digital scoring, and remote dynamic monitoring could transform refractory cancer pain from an unmeasurable ordeal into a precisely quantified, continuously tracked, and effectively treated condition, offering patients the chance to spend their final months in comfort and connection rather than in agony.

Subject of Research: Digital pain assessment technology for refractory cancer pain management

Article Title: Case Report: Application of the 6D BTS digital assessment system in the comprehensive management of refractory cancer pain in a patient with gallbladder carcinoma

Article References: Ren, J., Li, Y., Zhou, K., Wang, Y., Wang, Q., Hu, D., Song, T., Dong, H., Cheng, Z., Hu, C., Huang, K., Zhang, Y., & Zhuang, L. (2026). Case Report: Application of the 6D BTS digital assessment system in the comprehensive management of refractory cancer pain in a patient with gallbladder carcinoma. Frontiers in Pain Research, 7, Article 1808441. https://doi.org/10.3389/fpain.2026.1808441

Image Credits: AI Generated

DOI: 10.3389/fpain.2026.1808441

Keywords: cancer pain, refractory cancer pain, digital health, pain assessment, gallbladder carcinoma, robotics, patient-controlled analgesia, palliative care, artificial intelligence, oncology, Case, Report

The synthesis draws on two complementary reviews. The first examined empirical associations between pain and cognition in people with dementia and cognitive impairment, ultimately including twenty studies spanning cohort analyses, cross-sectional surveys, qualitative work, systematic reviews, experimental designs, and intervention trials. The second reviewed fourteen studies focused specifically on methodological approaches, cataloguing how pain, cognitive performance, and cultural variables are measured in this population. Both reviews followed Joanna Briggs Institute guidance for scoping reviews, searched PubMed and PsycINFO in 2021, and restricted inclusion to English-language articles published in the preceding five years. By integrating the two, the authors could examine not just what the evidence shows, but whether the instruments used to generate that evidence are fit for purpose.

On the empirical side, the picture is broadly consistent but far from uniform. Across the included studies, chronic and persistent pain were generally associated with poorer cognitive outcomes in older adults and dementia populations, with the strongest signals appearing in processing speed and executive functioning. Meta-analytic and cohort evidence cited in the synthesis points to accelerated cognitive decline among people with persistent pain, and a recent meta-analysis of longitudinal cohort studies indicates a small-to-moderate increase in dementia risk among individuals with chronic pain. Yet the relationship is not linear, and its magnitude varies with dementia subtype, disease severity, and the specific cognitive domains being measured.

Here is where the methodological critique bites. Much of the field relies on global cognitive screening tools such as the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), prized for their speed and practicality but limited in their sensitivity to the domain-specific impairments, in attention, working memory, executive control, and processing speed, that pain is thought to disrupt. Comprehensive neuropsychological batteries offer far greater specificity but are time-consuming and burdensome for participants with cognitive impairment, so they remain the exception. The result, the authors argue, is a homogenised representation of cognition in which nuanced pain-related differences are collapsed into single global scores, obscuring the very interactions researchers are trying to detect.

The pain side of the equation faces an even sharper contradiction. Self-report is widely regarded as the gold standard for pain assessment, but it becomes increasingly unreliable as cognitive decline progresses, precisely in the populations most affected by dementia. Observational tools such as the Pain Assessment in Advanced Dementia scale (PAINAD) offer an alternative, but they are vulnerable to observer interpretation and to an over-reliance on facial expressions, which may not fully capture an individual’s pain experience. A recent systematic review found that although dementia-specific tools like PAINAD are widely used in emergency departments, there is still no clear evidence that they improve the timeliness or effectiveness of analgesia compared with standard pain scales. Current practice, the synthesis suggests, may privilege observable behaviour over subjective experience, shaping the kind of evidence the field generates.

These methodological tensions lead the authors to a provocative reinterpretation: the much-discussed bidirectional relationship between pain and cognition should be treated with caution. The predominance of cross-sectional and observational designs limits causal inference, and inconsistencies across studies may partly reflect differences in cognitive measures and pain assessment strategies rather than genuine contradictions in the underlying biology. Chronic pain may plausibly impair cognition through attentional interference and reduced engagement in daily activities, while cognitive impairment may interfere with the recognition, communication, and reporting of pain, but disentangling these threads will require longitudinal research with multimodal assessment and more sensitive, domain-specific cognitive measures.

The most striking finding, however, concerns culture. Of the fourteen studies in the methodological review, only one made any explicit reference to ethnicity or cultural grouping; thirteen made no mention of cultural variables at all. Even where demographic information was collected, it was typically limited to broad categories without exploring how cultural context might shape pain reporting, expression, or cognitive test performance. Standardised cognitive assessments and pain measures were generally applied without discussion of cultural validity or cross-cultural applicability, and this absence was rarely acknowledged as a limitation, suggesting that cultural neutrality is often assumed rather than demonstrated.

The consequences are not abstract. Evidence from aged care research shows that pain prevalence may be comparable between immigrant and non-immigrant residents, yet non-English-speaking immigrants reported significantly higher pain intensity, and total pain severity was strongly associated with neuropsychiatric symptom burden across all groups. In neuropsychological assessment, Arabic-speaking populations face additional barriers related to diglossia, literacy levels, and translation issues, which can contribute to misinterpretation or over- or under-diagnosis of cognitive impairment. Interpreter services can support communication during clinical encounters, but they do not resolve the deeper problem that the assessment tools themselves may not be culturally or linguistically valid, particularly where performance is influenced by language structure, educational background, or cultural familiarity with test materials.

The authors argue that culture is not simply missing data but a structural limitation affecting how pain-cognition relationships are interpreted across diverse populations. When tools are applied without consideration of language, education, or migration-related factors, differences in reported pain or cognitive performance may be read as clinical differences when they partly reflect differences in assessment validity. The synthesis is careful to note that the evidence on Arabic-speaking migrants and refugees illustrates one important example of a broader need for culturally appropriate assessment rather than representing all culturally diverse populations, but the underlying pattern, tools developed and validated primarily in Western populations being applied as if universally applicable, recurs throughout the literature.

The path forward, the synthesis concludes, requires simultaneous reform on several fronts. Pain assessment should be tailored to the stage and severity of dementia, combining self-report where possible with observational and behavioural measures, clinical information, and input from caregivers, rather than applying a single method across the dementia spectrum. Research on pain-cognition relationships should favour domain-specific cognitive measures targeting executive functioning, attention, working memory, and processing speed, with greater consistency in outcome selection to improve comparability across studies. Cultural and linguistic factors, including language background, educational experience, ethnicity, and migration history, should be reported systematically, and researchers should verify whether their instruments have been validated for the populations they study. Finally, longitudinal research with multimodal assessment and careful attention to confounders such as dementia subtype, comorbidities, medication use, and demographic characteristics is needed to clarify whether observed associations reflect genuine clinical relationships, methodological artifacts, or an interaction of both. The authors acknowledge their own limitations, including the English-language and five-year restrictions of the underlying reviews and the interpretive nature of critical synthesis, but their central message stands: progress in understanding pain and dementia will demand not just better measurement, but a re-examination of the cultural assumptions embedded in how pain and cognition are defined in the first place.

Subject of Research: The relationship between pain and cognition in dementia and the methodological and cultural limitations of its assessment

Article Title: Pain, cognition, and culture in dementia research: a critical synthesis of empirical and methodological literature

Article References: Taqdees, R., Mercer, T., & Taiwo, A. O. (2026). Pain, cognition, and culture in dementia research: a critical synthesis of empirical and methodological literature. Frontiers in Pain Research, 7, Article 1797629. https://doi.org/10.3389/fpain.2026.1797629

Image Credits: AI Generated

DOI: 10.3389/fpain.2026.1797629

Keywords: dementia, chronic pain, cognition, pain assessment, cognitive assessment, cultural factors, scoping review, MMSE, MoCA, PAINAD, executive functioning, multimodal assessment

The study, published in BMC Psychology, is a secondary analysis of 822 consecutive patients treated at the university pain clinic’s outpatient department between February 2019 and July 2020. All patients completed their assessments through a validated digital tool called SymptomMapper, which requires sequential completion of every item before submission, a design feature that explains the near-perfect data completeness in the sample. The participants, roughly two-thirds of them women with an average age of 53.7 years, reported a mean pain intensity of 59.2 on the visual analogue scale. Their mean acceptable pain was 25.5, but the distribution was strikingly skewed: about 7 percent said no pain at all was acceptable, while 8 percent reported values of 50 or higher.

The researchers, led by Yannick Bruns, examined how the single acceptable-pain item related to six psychosocial outcomes: somatization measured with the PHQ-15, anxiety with the GAD-7, sleep impairment on a visual analogue scale, perceived stress with the PHQ stress module, depression with the PHQ-9, and pain-related disability with the Pain Disability Index. Crucially, the statistical models adjusted not just for one measure of pain severity but for three, the mean, maximum, and current pain intensity over the previous four weeks, along with trauma category, age, and sex. A Bonferroni correction set the significance threshold at 0.008 to guard against false positives across the six tests.

The results were consistent and, in one sense, counterintuitive. Each 10-point increase on the acceptable pain scale was associated with significantly greater somatization, anxiety, sleep impairment, and perceived stress. The association with depression fell just short of significance, and there was no association at all with functional disability. The incremental variance explained by acceptable pain was modest, between 0.8 and 1.4 percent for the four significant outcomes, but the direction of every significant association pointed the same way: higher tolerance, more psychological distress. Three prespecified sensitivity analyses, including one that excluded extreme values and another that dummy-coded trauma, left the pattern intact.

Why would a higher tolerance for pain signal worse rather than better mental health? The authors offer several non-exclusive explanations. The first is that the acceptable-pain question functions, in disguise, as an expectation item. A patient who answers that a pain level of 60 would be acceptable may be saying less about stoicism and more about hopelessness: they do not expect meaningful improvement, so they have lowered the bar for what they would settle for. Low treatment expectations are well documented predictors of poorer outcomes in chronic pain, which would make a high acceptable-pain score a marker of demoralization rather than resilience.

A second interpretation draws on response shift theory from quality-of-life research. People who live with relentless pain and psychosocial distress may recalibrate their internal standards upward, coming to accept higher pain levels not because they cope well but because they have adapted to suffering. Supporting this reading, trauma category was independently associated with higher acceptable pain in the dataset, and an exploratory post-hoc interaction test found that the acceptable-pain association with depression grew progressively stronger across trauma categories. In patients with no trauma history, the coefficient was essentially zero; in those with PTSD-level trauma, it rose to 0.67 per 10 scale points. The pattern was Bonferroni-significant, though the authors stress it was post hoc and requires replication.

The subgroup comparisons sharpen the picture. Patients who reported acceptable pain values of 50 or higher, just 66 people, had the highest proportion of PTSD-level trauma at 22.7 percent, the highest mean pain intensity at 77.2, and elevated scores on every psychosocial measure, including a mean PHQ-15 somatization score of 15.8, which crosses from the moderate into the severe range. At the opposite pole, the 58 patients who said no pain was acceptable were younger and had the lowest somatization, anxiety, and stress scores. These differences persisted after adjustment for all three pain intensity measures, meaning they cannot be explained away by the simple fact that the high-tolerance group hurt more.

The authors are careful to flag a methodological alternative that could partly account for the findings. Negative affectivity, the dispositional tendency to experience negative emotions, is known to inflate correlations between self-report measures. The specificity pattern in the data, significant associations with mood and symptom questionnaires but none with the disability index, is consistent with such shared reporting bias, since functional limitations may be less susceptible to it. The researchers also note that a single visual analogue item has no established psychometric properties and is semantically ambiguous: responses may reflect treatment expectations, resignation, normative beliefs about pain endurance, or strategic communication in a clinical encounter, and the cross-sectional design cannot disentangle these meanings.

What the study does establish, within its limits, is a sharp conceptual distinction between tolerance and acceptance. Established measures of pain acceptance, such as the Chronic Pain Acceptance Questionnaire, are consistently associated with lower distress; patients who accept pain while pursuing valued activities fare better psychologically. The acceptable-pain item behaved in exactly the opposite direction, and without the specificity that genuine acceptance shows. The authors hypothesize that acceptable pain reflects a tolerance threshold rather than a coping quality, and that the two may even be inversely related. They also connect the finding to earlier work showing that low pain tolerance on the Heidelberg screening predicts chronification of acute back pain, suggesting the present result may be a complementary observation in patients whose pain has already become chronic.

The clinical message is cautious but clear. Because acceptable pain is already collected in some pain clinics as part of intake procedures, the temptation to read a high value as a favorable sign is real. This study suggests that temptation should be resisted. A high acceptable-pain score, particularly in a patient with a trauma history, may instead prompt clinicians to look more closely at somatic symptoms, anxiety, sleep, and stress. The authors emphasize that the small effect sizes mean the item is not yet a validated screening tool, and prospective studies are needed to test whether baseline acceptable pain predicts psychosocial deterioration over time. But as a hypothesis-generating finding, it lands with force: the patients who claim they can bear the most may, in fact, be bearing the heaviest loads of all.

Subject of Research: The association between self-reported acceptable pain intensity and psychosocial symptom burden in chronic pain patients

Article Title: Self-reported acceptable pain intensity is associated with psychosocial burden beyond pain severity in chronic pain patients: a cross-sectional study

Article References: Bruns, Y., Manuel, J., Neumann, A., Eberhardt, M., & Karst, M. (2026). Self-reported acceptable pain intensity is associated with psychosocial burden beyond pain severity in chronic pain patients: a cross-sectional study. BMC Psychology, 14(1), Article 1473. https://doi.org/10.1186/s40359-026-05731-8

Image Credits: AI Generated

DOI: 10.1186/s40359-026-05731-8

Keywords: chronic pain, acceptable pain, psychosocial burden, somatization, anxiety, sleep impairment, perceived stress, trauma, PTSD, pain assessment, pain clinics, response shift

The core idea is deceptively simple: instead of asking patients how much it hurts, listen to their bodies. Pain triggers well-documented physiological responses across the autonomic nervous system. Heart rate and pulse change, breathing patterns shift, skin conductance rises as sweat gland activity increases, and body temperature can fluctuate. The Spanish team combined four low-cost sensors into a single wearable setup: a pulse sensor, a respiratory rate sensor, a body temperature sensor and a galvanic skin response sensor, which measures the electrical conductance of the skin. Each of these signals has previously been linked to pain in the clinical literature, but the Sevilla group’s contribution lies in fusing them together on hardware that costs a fraction of what conventional clinical monitoring equipment does.

The choice of hardware is central to the project’s ambition. Rather than streaming data to a cloud server or a powerful workstation, the researchers deployed their machine learning models directly onto a low-cost microcontroller, an approach known as EdgeAI. This matters for several reasons. First, running inference at the edge means the system can deliver pain predictions in real time without depending on network connectivity, which is essential in busy hospital wards and rehabilitation gyms. Second, keeping physiological data on the device rather than shipping it to remote servers reduces privacy risks, an increasingly important consideration for sensitive health information. Third, microcontrollers are cheap and power-efficient, meaning a finished system could plausibly be scaled to many patients without prohibitive cost.

To make the EdgeAI approach work, the team turned to shallow machine learning algorithms rather than the deep neural networks that dominate headlines. Deep models are powerful but computationally hungry; they generally cannot fit within the memory and processing constraints of a small microcontroller. The researchers instead trained and compared several classic algorithms: artificial neural networks with modest architectures, J48 decision trees, instance-based k-nearest-neighbors classifiers, and random forests. Each model was tasked with the same job: taking the physiological readings from the four sensors and classifying the patient’s state into one of three categories: mild, moderate or severe pain.

A crucial part of the effort was the dataset itself. No off-the-shelf repository of sensor readings matched to pain labels existed for this exact configuration, so the team collected data specifically for the study, annotating recordings with pain levels. This is where the inherent difficulty of the problem becomes visible. Pain perception varies enormously between individuals and is influenced by culture, sex, psychological state and context, factors that the authors themselves acknowledge complicate data collection, annotation and inference. The labels attached to any physiological recording are therefore approximations, filtered through the same subjective reporting the system is trying to supplement. Despite this noise, the models found meaningful structure in the signals.

The results are encouraging for such a constrained platform. The random forest architecture emerged as the clear winner, achieving an accuracy of 83.60 percent in distinguishing between mild, moderate and severe pain. All tested approaches exceeded 65 percent accuracy, well above the roughly 33 percent that random guessing across three classes would achieve. Beyond raw accuracy, the team reported a battery of complementary metrics that paint a fuller picture of performance. The Kappa statistic, which measures agreement above chance, reached 0.7306, generally considered substantial. The area under the ROC curve, a measure of the model’s ability to discriminate between classes across all thresholds, hit 0.9440, a strong result. Error measures were correspondingly modest: mean absolute error of 0.1590, root mean square error of 0.2815, relative absolute error of 0.3942 and relative squared error of 0.6268.

Those numbers should be read with appropriate caution, as the authors are careful to note. An 83.60 percent accuracy in a three-class problem with subjective labels is promising but not clinical perfection, and the system is proposed as a decision-support tool rather than a replacement for clinical judgment. Still, the fact that such performance is achievable with shallow models on a microcontroller is the real headline. It suggests that the physiological signature of pain, however noisy, is strong enough to be captured by cheap hardware and simple algorithms, democratizing a capability that previously required expensive laboratory equipment or complex multimodal setups involving brain imaging or facial video analysis.

The potential applications are broad. The researchers highlight rehabilitation sessions, where physiotherapists need continuous, objective feedback about how much pain a patient is experiencing during exercises, information that patients themselves may minimize or exaggerate. The system could also be useful during surgeries and postoperative monitoring, where anesthetized or sedated patients cannot report pain at all. Perhaps most strikingly, it could serve patients with speech disorders, who currently have no reliable way to communicate their pain level to caregivers. In all these scenarios, a continuous, wearable, automatic monitor could catch pain spikes that periodic verbal check-ins miss, leading to faster interventions and better pain management strategies.

The work also fits into a rapidly growing research landscape. Machine learning approaches to pain assessment have accelerated in recent years, with studies using electrodermal activity, facial video analysis, electroencephalography and multimodal neuroimaging to predict clinical pain. Many of these efforts rely on heavy computational resources, cloud processing or specialized sensors. The Sevilla system’s distinctive contribution is its radical pragmatism: four commodity sensors, one microcontroller, four classic algorithms and a mobile application that presents the predicted pain level to the user or clinician. The mobile app completes the loop, turning raw sensor streams into an interpretable evaluation that can inform care in real time.

Challenges remain before such a system reaches routine clinical use. The subjectivity of pain perception affects every stage of the pipeline, from how training data is labeled to how well a model generalizes to new patients whose baseline physiology differs from those in the training set. Larger and more diverse datasets, longitudinal validation in real hospitals, and regulatory scrutiny will all be necessary. Yet the direction of travel is clear. As edge computing hardware grows more capable and biosensors cheaper, objective, continuous pain monitoring is moving from the research lab toward the clinic. The Spanish team’s study, supported by the Andalusian DAFNE project and the Spanish Ministry of Science’s NEKOR project, offers a concrete demonstration that meaningful pain assessment does not need a supercomputer, just well-chosen signals, well-trained models and a chip small enough to wear.

Subject of Research: Automatic pain assessment using EdgeAI machine learning and low-cost physiological sensors

Article Title: Automatic pain assessment system based on EdgeAI and low-cost sensors

Article References: García Flores, J., Cabello Arango, C. A., Duran-Lopez, L., Cerezuela-Escudero, E., & Dominguez-Morales, J. P. (2026). Automatic pain assessment system based on EdgeAI and low-cost sensors. Neural Computing and Applications, 38(18), Article 740. https://doi.org/10.1007/s00521-026-12474-5

Image Credits: AI Generated

DOI: 10.1007/s00521-026-12474-5

Keywords: pain assessment, EdgeAI, machine learning, biosensors, microcontroller, random forest, galvanic skin response, rehabilitation, wearable sensors, embedded systems, neural networks, pain management

The review identifies three core challenges that have defined traditional pain management for decades. First, assessment depends on patients describing their own suffering, a process vulnerable to emotional state, cultural background and cognitive function, and effectively unusable for infants, dementia patients, the critically ill and postoperative patients who cannot self-report. Second, conventional imaging lacks the sensitivity to detect many pain-related structural changes: plain X-rays miss early osteoarthritis and soft tissue lesions, while MRI, despite excellent soft tissue resolution, struggles with functional pain and is expensive and time-consuming. Third, treatment selection relies on clinical experience and guidelines without individualized prediction, leaving roughly 30 to 40 percent of patients failing to respond adequately to their initial regimen. The result is prolonged suffering, repeated medication adjustments, rising costs and heightened risk of adverse drug reactions. Deep learning, the authors contend, offers an end-to-end pathway from symptom identification to mechanism analysis, extracting latent pain biomarkers from multi-source heterogeneous data.

The most technically rich portion of the review concerns objective pain assessment, where deep neural networks are being trained to quantify suffering from signals that patients cannot suppress. Computer vision models analyze facial micro-expressions such as frowning and squinting; speech systems capture changes in vocal tone, pitch jitter and spectral energy; and physiological pipelines integrate electroencephalography, skin conductance, heart rate variability and respiration. The performance figures are striking. A neonatal convolutional neural network recognizing pain from infant facial expressions achieved 91 percent accuracy with an area under the curve of 0.93, while a three-branch network analyzing newborn cries reached 96.77 percent accuracy in binary classification, using only about 2.6 percent of the parameters of VGG16. In adults, a spatial-temporal attention LSTM network classified postoperative pain into three levels from facial landmarks with 86.6 percent accuracy, and an autoencoder-LSTM model fused motion capture with surface electromyography to detect protective behaviors, improving over single-modality baselines by 38.5 percent.

Physiological signals have proven equally fertile ground. A framework called PainAttnNet, built on transformer architectures with multiscale feature extraction, classified pain intensity from electrodermal activity with 85.56 percent accuracy on the BioVid dataset. A dual-branch spatiotemporal model processing scalp EEG in children distinguished pain from non-pain states with 87.83 percent accuracy, and, notably, visualization of electrode contributions showed that accuracy remained at 84 percent even when only nine electrodes were retained, a finding that could dramatically simplify data collection in pediatric settings. A hybrid BiLSTM-support vector machine pipeline classified postoperative pain intensity from electrocardiographic signals at 84.14 percent validation accuracy, while bidirectional LSTMs applied to functional near-infrared spectroscopy achieved 90.6 percent accuracy across four pain intensity categories, outperforming unidirectional variants by 5 to 8.4 percentage points. Resting-state frontal EEG biomarkers have likewise been proposed for grading chronic neuropathic pain severity, moving the field closer to objective clinical translation.

Multimodal fusion, however, emerges as both the field’s greatest promise and its most sobering cautionary tale. Because any single signal can be lost in real clinical environments, obscured by oxygen masks, sedation, motion artifacts or equipment failure, fusing facial, vocal and physiological streams offers redundancy and robustness. In neonatal postoperative pain assessment, a decision-level voting fusion of facial expressions, body movements and crying maintained strong performance even when a quarter of each modality’s data was randomly removed, with the fused area under the curve of 0.868 clearly surpassing the best single modality at 0.774. Yet the review is candid that fusion is not a universal win: in real postoperative wards, single-modality models, particularly those using respiratory rate at 88.24 percent balanced accuracy, consistently outperformed multimodal fusion, which was degraded by motion artifacts, asynchronous acquisition and environmental noise rarely encountered in laboratory datasets. The authors call for cross-modal pretraining, medical knowledge graphs and event-driven fusion strategies to close this gap.

The second pillar of the review concerns intelligent structural identification, where convolutional and transformer-based models automatically segment the anatomical landscape of pain. Deep learning systems now detect lumbar spondylolisthesis from X-rays, quantify vertebral fractures through anchor-free keypoint detection with expert-level localization error of 0.92 millimeters and an AUC of 0.96, and grade intervertebral disc degeneration from MRI in real time using YOLOv5 architectures with over 95 percent classification accuracy. On the cervical spine, where vertebral similarity and complex anatomy make segmentation notoriously difficult, a 2D U-Net framework with superior-inferior labeling achieved Dice coefficients above 94 percent even on pathological data, and a transformer-based model reduced radiologist interpretation time for degenerative cervical MRI from up to 490 seconds to as little as 90 seconds, with the greatest benefit accruing to residents.

Nerve and needle localization extend this vision into interventional precision. Mask R-CNN-based systems segment the median nerve at the carpal tunnel from ultrasound without manual region selection, while U-Net variants track the vagus nerve in real time with over 90 percent recognition accuracy even in low-quality images, trained from mere bounding-box annotations. The dorsal root ganglion, a structure implicated in neuropathic pain but historically too small to segment automatically, has now been delineated in MRI using a meta-optimized nnU-Net framework, revealing genotype-related volume changes in a Fabry disease model. For ultrasound-guided nerve blocks, deep networks locate needle tips that are frequently invisible at steep angles: time-aware LSTMs combined with dynamic background subtraction recover weak tip echoes, and an optical-flow-enhanced YOLO variant tracks speckle dynamics of entirely invisible needles while cutting model parameters by 98 percent for real-time deployment, reaching sub-millimeter localization accuracy in robotic settings.

The third pillar maps AI onto specific pain conditions. For shoulder disorders, multimodal models fusing X-rays with clinical data rule out rotator cuff tears with 97.3 percent sensitivity, and 3D networks trained on more than 11,000 MRI studies classify full-thickness tears with AUCs as high as 0.99, outperforming experienced radiologists. In osteoarthritis, deep stacked ensembles grade knee severity at up to 99.71 percent accuracy, automated systems measure hip-knee-ankle angles 126.7 times faster than manual workflows, and a model called DeepKOA predicts structural and symptomatic progression over 24 to 48 months from multimodal MRI. Multiomic deep clustering has even identified three molecular subtypes of knee osteoarthritis that predict post-arthroplasty pain outcomes with AUCs of 0.84 to 0.88. For trigeminal neuralgia, machine learning on brain morphology predicted gamma knife surgery efficacy with 96.7 percent accuracy, and radiomics models now identify which patients will achieve durable relief from percutaneous balloon compression, lifting three-year pain-free survival in favorable subgroups from 51.1 percent to 86.4 percent. Machine learning models predicting postherpetic neuralgia from 23,326 real-world electronic health records, and LSTM networks forecasting cancer pain exacerbations hours before onset, illustrate the shift toward preemptive intervention.

The review closes with a bracing reality check. Most studies remain small, single-center and internally validated; when tested externally, performance routinely collapses, as when a sacroiliitis model’s sensitivity plummeted from near-expert levels to 56 percent. Data imbalance, annotation inconsistency, demographic bias and unmodeled anatomical variation pervade the literature, and explainable AI outputs often misalign with what clinicians actually need. Privacy risks from biometric pain data, unresolved liability frameworks, absent reimbursement mechanisms and the economic burden of deployment all stand between laboratory success and bedside reality. The authors argue that pain AI must now pivot from a method-driven race for benchmark accuracy to an evaluation-driven, utility-driven paradigm in which human-AI collaboration, longitudinal outcomes and patient-centered benefit define success. If that transition succeeds, the era in which suffering could only be described, rather than measured, understood and preempted, may finally be drawing to a close.

Subject of Research: Artificial intelligence applications in objective pain assessment, medical image analysis and treatment decision-making for chronic pain conditions

Article Title: Current state of research and future developments of artificial intelligence in pain diagnosis and treatment

Article References: Yang, Z., Li, L., Bo, S., Zhong, J., & Zhang, Y. (2026). Current state of research and future developments of artificial intelligence in pain diagnosis and treatment. Journal of Translational Medicine, 24(1), Article 1177. https://doi.org/10.1186/s12967-026-08529-9

Image Credits: AI Generated

DOI: 10.1186/s12967-026-08529-9

Keywords: artificial intelligence, chronic pain, deep learning, pain assessment, multimodal data fusion, medical imaging, trigeminal neuralgia, osteoarthritis, postherpetic neuralgia, cancer pain, explainable AI, precision medicine